BCPC — Balchem Income Statement
0.000.00%
- $5.00bn
- $5.14bn
- $953.68m
- 99
- 20
- 80
- 73
Annual income statement for Balchem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 704 | 799 | 942 | 922 | 954 |
Cost of Revenue | |||||
Gross Profit | 224 | 243 | 280 | 302 | 336 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 592 | 672 | 797 | 763 | 771 |
Operating Profit | 111 | 128 | 145 | 159 | 183 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 106 | 125 | 134 | 137 | 166 |
Provision for Income Taxes | |||||
Net Income After Taxes | 84.6 | 96.1 | 105 | 109 | 128 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 84.6 | 96.1 | 105 | 109 | 128 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 84.6 | 96.1 | 105 | 109 | 128 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.68 | 2.97 | 3.32 | 3.29 | 3.95 |
Dividends per Share |